Exploring the Effect of Nice Guidelines on Prescribing for Childhood Atopic Eczema in Primary Care with An Interrupted Time Series
Introduction Atopic eczema (AE) is a chronic inflammatory skin condition affecting 20-32% of UK children, typically diagnosed and treated in primary care. National Institute of Health and Clinical Excellence (NICE, 2007) guidelines recommend all children presenting with AE in primary care are prescr...
Príomhchruthaitheoirí: | LIW Schreuders, SJ Ersser, C Thompson |
---|---|
Formáid: | Alt |
Teanga: | English |
Foilsithe / Cruthaithe: |
Swansea University
2020-12-01
|
Sraith: | International Journal of Population Data Science |
Rochtain ar líne: | https://ijpds.org/article/view/1613 |
Míreanna comhchosúla
Míreanna comhchosúla
-
Impact of NICE guidance on tamoxifen prescribing in England 2011–2017: an interrupted time series analysis
de réir: Curtis, HJ, et al.
Foilsithe / Cruthaithe: (2018) -
Reply to Comment on ‘Impact of NICE guidance on tamoxifen prescribing in England 2011–2017: an interrupted time series analysis”
de réir: Curtis, H, et al.
Foilsithe / Cruthaithe: (2018) -
Management of Atopic Eczema in primary care
de réir: Ainol Haniza Kherul Anuwar, et al.
Foilsithe / Cruthaithe: (2020-03-01) -
Parents' and carers' views about emollients for childhood eczema: qualitative interview study.
de réir: Santer, M, et al.
Foilsithe / Cruthaithe: (2016) -
Childhood atopic eczema: children’s
Quality of life and family impact
de réir: Ghani, Ahmad Abir Ab
Foilsithe / Cruthaithe: (2012)